1160392

AbbVie Inc. — FEI 3009751352

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 15, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Chicago, IL (United States)

Additional Details

Sponsor, Contract Research Organization